Who invested in Adaptyv Bio?
Adaptyv Bio, a Biotech & Pharma startup from Switzerland, raised €34.35 million in a Series A round announced on 27 August 2026. Investors: Highland Europe (lead), ACE Ventures, byFounders VC and Y Combinator.
Adaptyv Bio
€34.35 millionSeries ABiotech & PharmaHighland EuropeleadACE VenturesbyFounders VCY Combinator
Switzerlandeu-startups.com
Questions founders ask
- Who invested in Adaptyv Bio?
- Highland Europe, ACE Ventures, byFounders VC and Y Combinator invested in Adaptyv Bio's Series A round, announced on 27 August 2026 (source: eu-startups.com).
- Who led Adaptyv Bio's Series A round?
- Highland Europe, according to eu-startups.com.
- How much did Adaptyv Bio raise?
- €34.35 million in its Series A round, as reported by eu-startups.com.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.